Literature DB >> 8065355

Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin.

J Zhou1, E N Olson.   

Abstract

The muscle-specific basic helix-loop-helix (bHLH) protein myogenin activates muscle transcription by binding to target sequences in muscle-specific promoters and enhancers as a heterodimer with ubiquitous bHLH proteins, such as the E2A gene products E12 and E47. We show that dimerization with E2A products potentiates phosphorylation of myogenin at sites within its amino- and carboxyl-terminal transcription activation domains. Phosphorylation of myogenin at these sites was mediated by the bHLH region of E2A products and was dependent on dimerization but not on DNA binding. Mutations of the dimerization-dependent phosphorylation sites resulted in enhanced transcriptional activity of myogenin, suggesting that their phosphorylation diminishes myogenin's transcriptional activity. The ability of E2A products to potentiate myogenin phosphorylation suggests that dimerization induces a conformational change in myogenin that unmasks otherwise cryptic phosphorylation sites or that E2A proteins recruit a kinase for which myogenin is a substrate. That phosphorylation of these dimerization-dependent sites diminished myogenin's transcriptional activity suggests that these sites are targets for a kinase that interferes with muscle-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065355      PMCID: PMC359150          DOI: 10.1128/mcb.14.9.6232-6243.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Cyclic AMP-dependent protein kinase phosphorylates and inactivates the yeast transcriptional activator ADR1.

Authors:  J R Cherry; T R Johnson; C Dollard; J R Shuster; C L Denis
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

2.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

3.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

4.  A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.

Authors:  D G Edmondson; E N Olson
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

5.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.

Authors:  S J Tapscott; R L Davis; M J Thayer; P F Cheng; H Weintraub; A B Lassar
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

6.  Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene.

Authors:  E A Sternberg; G Spizz; W M Perry; D Vizard; T Weil; E N Olson
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

7.  Phosphorylation inhibits the DNA-binding activity of MyoD homodimers but not MyoD-E12 heterodimers.

Authors:  K Mitsui; M Shirakata; B M Paterson
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

Review 8.  Signal transduction via the MAP kinases: proceed at your own RSK.

Authors:  J Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

Authors:  W E Wright; D A Sassoon; V K Lin
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

10.  A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.

Authors:  T Braun; G Buschhausen-Denker; E Bober; E Tannich; H H Arnold
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  7 in total

1.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Prediction of functional regions of the maize streak virus replication-associated proteins by protein-protein interaction analysis.

Authors:  G V Horváth; A Pettkó-Szandtner; K Nikovics; M Bilgin; M Boulton; J W Davies; C Gutiérrez; D Dudits
Journal:  Plant Mol Biol       Date:  1998-11       Impact factor: 4.076

3.  TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Theodore P Abraham; Vlad C Vasile; Michael J Ackerman; David G Monroe; Teng-Leong Chew; Thomas C Spelsberg
Journal:  J Cell Biochem       Date:  2007-02-01       Impact factor: 4.429

4.  Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.

Authors:  S X Skapek; J Rhee; P S Kim; B G Novitch; A B Lassar
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

5.  Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes.

Authors:  Mònica Suelves; Frederic Lluís; Vanessa Ruiz; Angel R Nebreda; Pura Muñoz-Cánoves
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

6.  The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants.

Authors:  D Tedesco; M Caruso; L Fischer-Fantuzzi; C Vesco
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Sumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis.

Authors:  Hosouk Joung; Sehee Kwon; Kyoung-Hoon Kim; Yun-Gyeong Lee; Sera Shin; Duk-Hwa Kwon; Yeong-Un Lee; Taewon Kook; Nakwon Choe; Jeong Chul Kim; Young-Kook Kim; Gwang Hyeon Eom; Hyun Kook
Journal:  Exp Mol Med       Date:  2018-01-12       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.